Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial

समान संसाधन

• GE-08 TARGETED NEXT GENERATION SEQUENCING OF ARCHIVAL FFPE SAMPLES FROM EORTC STUDY 26951 SHOWS STRONG PROGNOSTIC VALUE OF A MOLECULAR CLASSIFICATION IN LOCALLY DIAGNOSED GRADE III OLIGODENDROGLIOMA
  द्वारा: Dubbink, Hendrikus, और अन्य
  प्रकाशित: (2014)
• MGMT Promoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Study 26951
  द्वारा: van den Bent, Martin J., और अन्य
  प्रकाशित: (2009)
• LTBK-12. EORTC 26951, RANDOMIZED STUDY OF ADJUVANT PCV AFTER 59.4 GY RADIOTHERAPY: VERY LONG TERM FOLLOW-UP
  द्वारा: van den Bent, Martin, और अन्य
  प्रकाशित: (2019)
• Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951
  द्वारा: Idbaih, Ahmed, और अन्य
  प्रकाशित: (2010)
• Intrinsic Molecular Subtypes of Glioma Are Prognostic and Predict Benefit From Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Combination With Other Prognostic Factors in Anaplastic Oligodendroglial Brain Tumors: A Report From EORTC Study 26951
  द्वारा: Erdem-Eraslan, Lale, और अन्य
  प्रकाशित: (2013)